Suppr超能文献

提高经导管主动脉瓣置换手术的效率:1000例经导管主动脉瓣置换手术的经验

Improving Efficiency in Performing Transcatheter Aortic Valve Replacement Procedure: Experience With 1000 TAVR Procedures.

作者信息

Quader Mohammed, Shah Neha, Deitch Rebecca, Lawson Barbara, Endicott Delia, Gertz Zachary

机构信息

Division of Cardiothoracic Surgery, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia.

Pauley Heart Center, Virginia Commonwealth University Health, Richmond, Virginia.

出版信息

Struct Heart. 2025 Apr 3;9(8):100467. doi: 10.1016/j.shj.2025.100467. eCollection 2025 Aug.

Abstract

BACKGROUND

Since Food and Drug Administration approval of transcatheter aortic valve replacement (TAVR) in 2011, advancements in technology and procedural refinements have improved efficiency and safety. By systematically eliminating steps in the original TAVR protocol, we achieved reductions in procedural time, contrast volume, and fluoroscopy time without compromising outcomes.

METHODS

Institutional TAVR data (November 2012 to September 2023) were analyzed, focusing on procedural times, contrast volume, radiation exposure, and outcomes. Four protocol modifications were compared: traditional protocol (2012 to 2016), elimination of rotational angiogram (2017 to 2020), elimination of balloon valvuloplasty (2020 to 2022), and elimination of femoral angiogram (2022 to 2023).

RESULTS

Among 1095 TAVR procedures, 88.5% were femoral access, and 86.0% were done under conscious sedation. The mean age of patients was 79.0 ± 8.7 years, with 59% males. Most patients were classified in the Society of Thoracic Surgeons intermediate-risk category (38.4%), followed by prohibitive risk (30.0%), high risk (23.9%), and low risk (7.4%). Average procedural time, contrast volume, and fluoroscopy time were 88.4 ± 38.0 ​minutes, 73.0 ± 38.8 mL, and 13.8 ± 7.9 ​minutes, respectively. Adverse events occurred in 15%, with vascular complications (3.7%) being the most common. Mortality was 1.5%, highest in transapical (15%) and lowest in femoral (0.3%). Protocol modifications were associated with significant reductions in procedural time (59.99 ± 15.2 vs. 97.8 ± 33.9 ​minutes), contrast use (40.1 ± 26.6 vs. 92.9 ± 38.1 mL), fluoroscopy time (8.6 ± 7.4 vs. 18.5 ± 8.5 ​minutes), and complications (5.5 vs. 25.6%), all ​< ​0.001.

CONCLUSIONS

Systematic elimination of procedural steps was associated with reduced procedural time, contrast use, and fluoroscopy time, without compromising patient safety. These refinements may enhance procedural efficiency and patient outcomes.

摘要

背景

自2011年美国食品药品监督管理局批准经导管主动脉瓣置换术(TAVR)以来,技术进步和手术流程优化提高了效率和安全性。通过系统地消除原始TAVR方案中的步骤,我们在不影响手术效果的情况下,实现了手术时间、造影剂用量和透视时间的减少。

方法

分析了机构TAVR数据(2012年11月至2023年9月),重点关注手术时间、造影剂用量、辐射暴露和手术效果。比较了四项方案修改:传统方案(2012年至2016年)、取消旋转血管造影(2017年至2020年)、取消球囊瓣膜成形术(2020年至2022年)和取消股动脉血管造影(2022年至2023年)。

结果

在1095例TAVR手术中,88.5%为股动脉入路,86.0%在清醒镇静下完成。患者的平均年龄为79.0±8.7岁,男性占59%。大多数患者被归类为胸外科医师协会中度风险类别(38.4%),其次是禁忌风险(30.0%)、高风险(23.9%)和低风险(7.4%)。平均手术时间、造影剂用量和透视时间分别为88.4±38.0分钟、73.0±38.8毫升和13.8±7.9分钟。15%的患者发生不良事件,血管并发症(3.7%)最为常见。死亡率为1.5%,经心尖入路最高(15%),股动脉入路最低(0.3%)。方案修改与手术时间(59.99±15.2 vs. 97.8±33.9分钟)、造影剂使用量(40.1±26.6 vs. 92.9±38.1毫升)、透视时间(8.6±7.4 vs. 18.5±8.5分钟)和并发症(5.5% vs. 25.6%)的显著减少相关,所有P值均<0.001。

结论

系统地消除手术步骤与减少手术时间、造影剂使用量和透视时间相关,且不影响患者安全。这些改进可能会提高手术效率和患者手术效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b89c/12399234/090cb46f7c6e/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验